R. Niyazov

From Reflection to Implementation: Tailored Clinical Development of a Pembrolizumab Biosimilar Candidate.

Regulatory science increasingly recognizes that comparative efficacy studies may provide limited additional certainty to biosimilar development when high-resolution analytical, functional, and pharmacokinetic data robustly demonstrate similarity to the reference product. Modern structural and functional assays, combine...